AVDL•benzinga•
Oppenheimer Maintains Outperform on Avadel Pharmaceuticals, Raises Price Target to $30
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on October 31, 2024 by benzinga